These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 27181607

  • 1. Effect of DSP4 and desipramine in the sensorial and affective component of neuropathic pain in rats.
    Bravo L, Mico JA, Rey-Brea R, Camarena-Delgado C, Berrocoso E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct 03; 70():57-67. PubMed ID: 27181607
    [Abstract] [Full Text] [Related]

  • 2. The brain-penetrant 5-HT7 receptor agonist LP-211 reduces the sensory and affective components of neuropathic pain.
    Santello M, Bisco A, Nevian NE, Lacivita E, Leopoldo M, Nevian T.
    Neurobiol Dis; 2017 Oct 03; 106():214-221. PubMed ID: 28690143
    [Abstract] [Full Text] [Related]

  • 3. Central noradrenergic lesion induced by DSP-4 impairs the acquisition of avoidance reactions and prevents molecular changes in the amygdala.
    Radwanska K, Nikolaev E, Kaczmarek L.
    Neurobiol Learn Mem; 2010 Oct 03; 94(3):303-11. PubMed ID: 20650329
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Repeated Administration of Amitriptyline in Neuropathic Pain: Modulation of the Noradrenergic Descending Inhibitory System.
    Hiroki T, Suto T, Saito S, Obata H.
    Anesth Analg; 2017 Oct 03; 125(4):1281-1288. PubMed ID: 28787345
    [Abstract] [Full Text] [Related]

  • 6. Behavioral effects of combined morphine and MK-801 administration to the locus coeruleus of a rat neuropathic pain model.
    Llorca-Torralba M, Mico JA, Berrocoso E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun 08; 84(Pt A):257-266. PubMed ID: 29524514
    [Abstract] [Full Text] [Related]

  • 7. Effects of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on alpha2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain.
    Prieto M, Giralt MT.
    Pharmacol Toxicol; 2001 Mar 08; 88(3):152-8. PubMed ID: 11245411
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological characterisation of place escape/avoidance behaviour in the rat chronic constriction injury model of neuropathic pain.
    Pedersen LH, Blackburn-Munro G.
    Psychopharmacology (Berl); 2006 Apr 08; 185(2):208-17. PubMed ID: 16479373
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of different classes of histamine H1 and H2 receptor antagonist effects on neuropathic nociceptive behavior following tibial nerve transection in rats.
    Khalilzadeh E, Azarpey F, Hazrati R, Vafaei Saiah G.
    Eur J Pharmacol; 2018 Sep 05; 834():221-229. PubMed ID: 30009812
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of anterior cingulate cortex lesion on mechanical hypersensitivity and escape/avoidance behavior in an animal model of neuropathic pain.
    LaGraize SC, Labuda CJ, Rutledge MA, Jackson RL, Fuchs PN.
    Exp Neurol; 2004 Jul 05; 188(1):139-48. PubMed ID: 15191810
    [Abstract] [Full Text] [Related]

  • 11. The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain.
    Alba-Delgado C, Borges G, Sánchez-Blázquez P, Ortega JE, Horrillo I, Mico JA, Meana JJ, Neto F, Berrocoso E.
    Psychopharmacology (Berl); 2012 May 05; 221(1):53-65. PubMed ID: 22038538
    [Abstract] [Full Text] [Related]

  • 12. DSP4-induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion.
    Archer T, Ogren SO, Johansson G, Ross SB.
    Psychopharmacology (Berl); 1982 May 05; 76(4):303-9. PubMed ID: 6812102
    [Abstract] [Full Text] [Related]

  • 13. The onset of treatment with the antidepressant desipramine is critical for the emotional consequences of neuropathic pain.
    Alba-Delgado C, Llorca-Torralba M, Mico JA, Berrocoso E.
    Pain; 2018 Dec 05; 159(12):2606-2619. PubMed ID: 30130302
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4.
    Wolfman C, Abó V, Calvo D, Medina J, Dajas F, Silveira R.
    Neurochem Int; 1994 Oct 05; 25(4):395-400. PubMed ID: 7820072
    [Abstract] [Full Text] [Related]

  • 17. A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat.
    Szot P, Miguelez C, White SS, Franklin A, Sikkema C, Wilkinson CW, Ugedo L, Raskind MA.
    Neuroscience; 2010 Mar 10; 166(1):279-91. PubMed ID: 20045445
    [Abstract] [Full Text] [Related]

  • 18. Antinociceptive effects of neurotropin in a rat model of central neuropathic pain: DSP-4 induced noradrenergic lesion.
    Kudo T, Kushikata T, Kudo M, Kudo T, Hirota K.
    Neurosci Lett; 2011 Sep 26; 503(1):20-2. PubMed ID: 21843596
    [Abstract] [Full Text] [Related]

  • 19. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.
    Jonsson G, Hallman H, Sundström E.
    Neuroscience; 1982 Sep 26; 7(11):2895-907. PubMed ID: 7155358
    [Abstract] [Full Text] [Related]

  • 20. Role of norepinephrine in forebrain and brainstem seizures: chemical lesioning of locus ceruleus with DSP4.
    Mishra PK, Burger RL, Bettendorf AF, Browning RA, Jobe PC.
    Exp Neurol; 1994 Jan 26; 125(1):58-64. PubMed ID: 8307124
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.